These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases. Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402 [TBL] [Abstract][Full Text] [Related]
23. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study. Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875 [TBL] [Abstract][Full Text] [Related]
24. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy. Dursun N; Dursun E; Alican D Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363 [TBL] [Abstract][Full Text] [Related]
25. Long-term effects of botulinum toxin A in children with cerebral palsy. Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845 [TBL] [Abstract][Full Text] [Related]
26. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases. Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274 [TBL] [Abstract][Full Text] [Related]
27. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy. Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658 [TBL] [Abstract][Full Text] [Related]
28. [Botulinum toxin Type A. Indications and results]. Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515 [TBL] [Abstract][Full Text] [Related]
29. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Ackman JD; Russman BS; Thomas SS; Buckon CE; Sussman MD; Masso P; Sanders J; D'Astous J; Aiona MD; Dev Med Child Neurol; 2005 Sep; 47(9):620-7. PubMed ID: 16138670 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts. Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850 [TBL] [Abstract][Full Text] [Related]
31. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy. Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987 [TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial. Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252 [TBL] [Abstract][Full Text] [Related]
33. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Farina S; Migliorini C; Gandolfi M; Bertolasi L; Casarotto M; Manganotti P; Fiaschi A; Smania N Funct Neurol; 2008; 23(2):87-91. PubMed ID: 18671909 [TBL] [Abstract][Full Text] [Related]
34. [Muscular lengthening of the triceps by successive casts in children with cerebral palsy]. Cottalorda J; Gautheron V; Charmet E; Chavrier Y Rev Chir Orthop Reparatrice Appar Mot; 1997; 83(4):368-71. PubMed ID: 9452811 [TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin and cerebral palsy: time for reflection? Gough M; Fairhurst C; Shortland AP Dev Med Child Neurol; 2005 Oct; 47(10):709-12. PubMed ID: 16174320 [TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. Kanovský P; Bares M; Severa S; Richardson A; Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586 [TBL] [Abstract][Full Text] [Related]
37. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury]. Xing ST; Wang D; Wen XH; Wu ZQ; Sun Q; Zhang DW; Cheng Y; Yan D; Yu F Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group. Koman LA; Mooney JF; Smith BP; Walker F; Leon JM J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699 [TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy. Gibson N; Graham HK; Love S Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606 [TBL] [Abstract][Full Text] [Related]
40. [Use of botulinum toxin in the preventive and palliative treatment of the hips in children with infantile cerebral palsy]. Pascual-Pascual SI Rev Neurol; 2003 Jul 1-15; 37(1):80-2. PubMed ID: 12861516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]